Unveiling the enigma of the CNS as a B-cell fostering environment

被引:65
作者
Uccelli, A [1 ]
Aloisi, F
Pistoia, V
机构
[1] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Neuroimmunol Unit, I-16126 Genoa, Italy
[2] Univ Genoa, Ctr Excellence Biomed Res, I-16126 Genoa, Italy
[3] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy
[4] G Gaslini Inst Children, Lab Oncol, Genoa, Italy
关键词
D O I
10.1016/j.it.2005.02.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This Opinion deals with the apparent paradox between the 'immune privileged' status of the central nervous system (CNS) and its propensity to act as a B-cell fostering environment in a variety of neurological disorders. Evidence will be reviewed that: (i) molecules regulating B-cell homing and survival are produced in the CNS, (ii) in different neuroinflammatory diseases, B cells can undergo a local recapitulation of the differentiation occurring in secondary lymphoid organs and (iii) ectopic lymphoid follicles develop in the meninges of multiple sclerosis (MS) patients.
引用
收藏
页码:254 / 259
页数:6
相关论文
共 62 条
[51]   Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis [J].
Serafini, B ;
Rosicarelli, B ;
Magliozzi, R ;
Stigliano, E ;
Aloisi, F .
BRAIN PATHOLOGY, 2004, 14 (02) :164-174
[52]   Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma [J].
Smith, JR ;
Braziel, RM ;
Paoletti, S ;
Lipp, M ;
Uguccioni, M ;
Rosenbaum, JT .
BLOOD, 2003, 101 (03) :815-821
[53]   Immunoglobulin class switching [J].
Stavnezer, J .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (02) :199-205
[54]   Multiple sclerosis: In situ evidence for antibody and complement-mediated demyelination [J].
Storch, MK ;
Piddlesden, S ;
Haltia, M ;
Iivanainen, M ;
Morgan, P ;
Lassmann, H .
ANNALS OF NEUROLOGY, 1998, 43 (04) :465-471
[55]   Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells [J].
Taga, S ;
Carlier, K ;
Mishal, Z ;
Capoulade, C ;
Mangeney, M ;
Lecluse, Y ;
Coulaud, D ;
Tetaud, C ;
Pritchard, LL ;
Tursz, T ;
Wiels, J .
BLOOD, 1997, 90 (07) :2757-2767
[56]   Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1 [J].
Tétaud, C ;
Falguières, T ;
Carlier, K ;
Lécluse, Y ;
Garibal, J ;
Coulaud, D ;
Busson, P ;
Steffensen, R ;
Clausen, H ;
Johannes, L ;
Wiels, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :45200-45208
[57]   Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis [J].
Thangarajh, M ;
Gomes, A ;
Masterman, T ;
Hillert, J ;
Hjelmström, P .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 152 (1-2) :183-190
[58]   Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis [J].
Vincent, A ;
Buckley, C ;
Schott, JM ;
Baker, I ;
Dewar, BK ;
Detert, N ;
Clover, L ;
Parkinson, A ;
Bien, CG ;
Omer, S ;
Lang, B ;
Rossor, MN ;
Palace, J .
BRAIN, 2004, 127 :701-712
[59]   Somatic hypermutation of immunoglobulin genes [J].
Wagner, SD ;
Neuberger, MS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :441-457
[60]   Lymphocyte targeting of the central nervous system: A review of afferent and efferent CNS-immune pathways. [J].
Weller, RO ;
Engelhardt, B ;
Phillips, MJ .
BRAIN PATHOLOGY, 1996, 6 (03) :275-288